| Robert Harkness, | |
|
1601 N Church St, Atkins, AR 72823-3234 | |
| (479) 641-7878 | |
| (479) 641-2294 |
| Full Name | Robert Harkness |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1601 N Church St, Atkins, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356745368 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 6004 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Harkness, 1601 N Church St, Po Box 155, Atkins, AR 72823-3234 Ph: (479) 641-7878 | Robert Harkness, 1601 N Church St, Atkins, AR 72823-3234 Ph: (479) 641-7878 |
News Archive
Epeius Biotechnologies Corporation has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene delivery to primary cancers and metastatic lesions that have spread throughout the body.
Beckman Coulter Life Sciences continues to expand the multi-parameter capabilities of its patented CytoFLEX flow cytometer technology.
Some types of breast cancer can be successfully treated with drugs such as tamoxifen, but treatment for a type of breast cancer more common in young and black women is still limited to radiation and general chemotherapy. Called triple negative breast cancer, this type of cancer is the focus of a 20-month, $8.6-million research project that aims to find new diagnostic tools and options for drugs.
DePuy Synthes Spine announced the global launch of "mPACT" (medialized Posterior Approach Cortical Trajectory), a program that combines implants, education, clinical research and procedural support for posterior mini open fixation and fusion procedures.
Archimedes Pharma, an emerging specialty pharma company focused on oncology, pain, neurology and critical care sectors, today announced publication of results from a Phase III, long-term safety, tolerability and consistency of effect, clinical study of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTCP).
› Verified 7 days ago
Dr. Misti D Evans, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1601b N Church St, Atkins, AR 72823 Phone: 479-641-7878 | |
Bryan Steven Hays, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1601b N Church St, Atkins, AR 72823 Phone: 479-641-7878 Fax: 479-641-2294 | |
Dr. Lorie Ann Steuber, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 408 N Church St, Atkins, AR 72823 Phone: 479-641-7878 |